vs
亚玛芬体育（AS）与MAXIMUS, INC.（MMS）财务数据对比。点击上方公司名可切换其他公司
MAXIMUS, INC.的季度营收约是亚玛芬体育的1.3倍（$1.3B vs $1.1B），MAXIMUS, INC.净利率更高（7.0% vs 1.8%，领先5.2%），亚玛芬体育自由现金流更多（$92.2M vs $-250.7M）
亚玛芬体育是芬兰跨国运动装备企业，总部位于赫尔辛基，成立于1950年。早年为涉足烟草贸易、航运、出版等领域的多元化工业集团，后逐步转型专注于体育用品的生产与营销，现有员工超9700人，2018年起成为中国安踏体育旗下子公司。
MAXIMUS是美国一家政府服务企业，业务覆盖美国、加拿大、英国等国家，为医疗补助、联邦医疗保险、医改、就业帮扶、学生贷款服务等各类政府项目提供行政及配套服务。公司总部位于弗吉尼亚州泰森斯，现有员工3.96万名，2024财年营收达53亿美元。
AS vs MMS — 直观对比
营收规模更大
MMS
是对方的1.3倍
$1.1B
净利率更高
MMS
高出5.2%
1.8%
自由现金流更多
AS
多$342.9M
$-250.7M
损益表 — Q1 FY2024 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.3B |
| 净利润 | $19.0M | $93.9M |
| 毛利率 | 52.8% | 23.7% |
| 营业利润率 | 12.4% | 10.9% |
| 净利率 | 1.8% | 7.0% |
| 营收同比 | — | -4.1% |
| 净利润同比 | — | 128.0% |
| 每股收益（稀释后） | $0.05 | $1.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMMS
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | $1.1B | $1.3B |
净利润ASMMS
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $75.3M | ||
| Q2 25 | — | $106.0M | ||
| Q1 25 | — | $96.6M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | $72.5M | ||
| Q2 24 | — | $89.8M | ||
| Q1 24 | $19.0M | $80.5M |
毛利率ASMMS
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 25.3% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | 52.8% | 23.6% |
营业利润率ASMMS
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | — | 10.8% | ||
| Q1 24 | 12.4% | 9.5% |
净利率ASMMS
| Q4 25 | — | 7.0% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | 1.8% | 6.0% |
每股收益（稀释后）ASMMS
| Q4 25 | — | $1.70 | ||
| Q3 25 | — | $1.27 | ||
| Q2 25 | — | $1.86 | ||
| Q1 25 | — | $1.69 | ||
| Q4 24 | — | $0.69 | ||
| Q3 24 | — | $1.18 | ||
| Q2 24 | — | $1.46 | ||
| Q1 24 | $0.05 | $1.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $137.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.7B |
| 总资产 | — | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMMS
| Q4 25 | — | $137.6M | ||
| Q3 25 | — | $222.4M | ||
| Q2 25 | — | $59.8M | ||
| Q1 25 | — | $108.1M | ||
| Q4 24 | — | $72.7M | ||
| Q3 24 | — | $183.1M | ||
| Q2 24 | — | $102.8M | ||
| Q1 24 | — | $77.4M |
股东权益ASMMS
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $1.8B |
总资产ASMMS
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $4.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.3M | $-244.4M |
| 自由现金流经营现金流 - 资本支出 | $92.2M | $-250.7M |
| 自由现金流率自由现金流/营收 | 8.8% | -18.6% |
| 资本支出强度资本支出/营收 | 2.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 6.02× | -2.60× |
| 过去12个月自由现金流最近4个季度 | — | $218.5M |
8季度趋势，按日历期对齐
经营现金流ASMMS
| Q4 25 | — | $-244.4M | ||
| Q3 25 | — | $649.4M | ||
| Q2 25 | — | $-182.7M | ||
| Q1 25 | — | $42.7M | ||
| Q4 24 | — | $-80.0M | ||
| Q3 24 | — | $163.8M | ||
| Q2 24 | — | $199.3M | ||
| Q1 24 | $114.3M | $130.5M |
自由现金流ASMMS
| Q4 25 | — | $-250.7M | ||
| Q3 25 | — | $641.8M | ||
| Q2 25 | — | $-198.2M | ||
| Q1 25 | — | $25.5M | ||
| Q4 24 | — | $-103.0M | ||
| Q3 24 | — | $131.9M | ||
| Q2 24 | — | $164.6M | ||
| Q1 24 | $92.2M | $105.2M |
自由现金流率ASMMS
| Q4 25 | — | -18.6% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | -14.7% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | -7.3% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | 8.8% | 7.8% |
资本支出强度ASMMS
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | 2.1% | 1.9% |
现金转化率ASMMS
| Q4 25 | — | -2.60× | ||
| Q3 25 | — | 8.63× | ||
| Q2 25 | — | -1.72× | ||
| Q1 25 | — | 0.44× | ||
| Q4 24 | — | -1.94× | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.22× | ||
| Q1 24 | 6.02× | 1.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AS
| Americas2 | $409.6M | 39% |
| EMEA1 | $356.9M | 34% |
| Greater China3 | $205.6M | 20% |
| Asia Pacific4 | $78.2M | 7% |
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
